Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability

Chromothripsis represents a mechanism of massive chromosome shattering and reassembly leading to the formation of derivative chromosomes with abnormal functions and expression. It has been observed in many cancer types, importantly, including chronic lymphocytic leukemia (CLL). Due to the associated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kristyna Zavacka, Karla Plevova
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4374ef7ff7ac4271b02f42a6e28a0dd0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4374ef7ff7ac4271b02f42a6e28a0dd0
record_format dspace
spelling oai:doaj.org-article:4374ef7ff7ac4271b02f42a6e28a0dd02021-12-01T06:55:33ZChromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability2234-943X10.3389/fonc.2021.771664https://doaj.org/article/4374ef7ff7ac4271b02f42a6e28a0dd02021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.771664/fullhttps://doaj.org/toc/2234-943XChromothripsis represents a mechanism of massive chromosome shattering and reassembly leading to the formation of derivative chromosomes with abnormal functions and expression. It has been observed in many cancer types, importantly, including chronic lymphocytic leukemia (CLL). Due to the associated chromosomal rearrangements, it has a significant impact on the pathophysiology of the disease. Recent studies have suggested that chromothripsis may be more common than initially inferred, especially in CLL cases with adverse clinical outcome. Here, we review the main features of chromothripsis, the challenges of its assessment, and the potential benefit of its detection. We summarize recent findings of chromothripsis occurrence across hematological malignancies and address its causes and consequences in the context of CLL clinical features, as well as chromothripsis-related molecular abnormalities described in published CLL studies. Furthermore, we discuss the use of the current knowledge about genome functions associated with chromothripsis in the optimization of treatment strategies in CLL.Kristyna ZavackaKristyna ZavackaKarla PlevovaKarla PlevovaKarla PlevovaFrontiers Media S.A.articlechromothripsischronic lymphocytic leukemiacomplex chromosomal rearrangementscopy number alterationsgenomic arraypaired-end sequencingNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic chromothripsis
chronic lymphocytic leukemia
complex chromosomal rearrangements
copy number alterations
genomic array
paired-end sequencing
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle chromothripsis
chronic lymphocytic leukemia
complex chromosomal rearrangements
copy number alterations
genomic array
paired-end sequencing
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Kristyna Zavacka
Kristyna Zavacka
Karla Plevova
Karla Plevova
Karla Plevova
Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
description Chromothripsis represents a mechanism of massive chromosome shattering and reassembly leading to the formation of derivative chromosomes with abnormal functions and expression. It has been observed in many cancer types, importantly, including chronic lymphocytic leukemia (CLL). Due to the associated chromosomal rearrangements, it has a significant impact on the pathophysiology of the disease. Recent studies have suggested that chromothripsis may be more common than initially inferred, especially in CLL cases with adverse clinical outcome. Here, we review the main features of chromothripsis, the challenges of its assessment, and the potential benefit of its detection. We summarize recent findings of chromothripsis occurrence across hematological malignancies and address its causes and consequences in the context of CLL clinical features, as well as chromothripsis-related molecular abnormalities described in published CLL studies. Furthermore, we discuss the use of the current knowledge about genome functions associated with chromothripsis in the optimization of treatment strategies in CLL.
format article
author Kristyna Zavacka
Kristyna Zavacka
Karla Plevova
Karla Plevova
Karla Plevova
author_facet Kristyna Zavacka
Kristyna Zavacka
Karla Plevova
Karla Plevova
Karla Plevova
author_sort Kristyna Zavacka
title Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
title_short Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
title_full Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
title_fullStr Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
title_full_unstemmed Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
title_sort chromothripsis in chronic lymphocytic leukemia: a driving force of genome instability
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4374ef7ff7ac4271b02f42a6e28a0dd0
work_keys_str_mv AT kristynazavacka chromothripsisinchroniclymphocyticleukemiaadrivingforceofgenomeinstability
AT kristynazavacka chromothripsisinchroniclymphocyticleukemiaadrivingforceofgenomeinstability
AT karlaplevova chromothripsisinchroniclymphocyticleukemiaadrivingforceofgenomeinstability
AT karlaplevova chromothripsisinchroniclymphocyticleukemiaadrivingforceofgenomeinstability
AT karlaplevova chromothripsisinchroniclymphocyticleukemiaadrivingforceofgenomeinstability
_version_ 1718405407846694912